Actuate Therapeutics To Sell 50,000,000 Shares At Assumed Price Of $0.819 Per Share

Actuate Therapeutics has announced plans to sell 50,000,000 shares at an assumed price of $0.819 per share, according to a recent SEC filing. This move is expected to raise significant capital for the company. The stock ticker for Actuate Therapeutics is ACTU.